
Faculty, Staff and Student Publications
Publication Date
9-27-2022
Journal
ACS Omega
Abstract
Addressing the growing burden of cancer and the shortcomings of chemotherapy in cancer treatment are the current research goals. Research to overcome the limitations of curcumin and to improve its anticancer activity via its heterocycle-fused monocarbonyl analogues (MACs) has immense potential. In this study, 32 asymmetric MACs fused with 1-aryl-1
DOI
10.1021/acsomega.2c02933
PMID
36188331
PMCID
PMC9520563
PubMedCentral® Posted Date
September 2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes